Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)

University of Zurich (UZH)

Status and phase: Completed; Phase 3

Conditions: Calcinosis Cutis in Connective Tissue Disease

Treatments: Device: shock wave therapy with Modulith SLK (Storz)

Study type: Interventional

Funder types: Other

Identifiers

NCT01683500

CCESWT01

Details and patient eligibility

About

Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy. The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters are: change in pain, size of the calcinosis, of possible ulcers and intake of painkillers.

• Trial with medical device

Full description

Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy (medical device). The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters are: change in pain (questionnaire), size of the calcinosis (ultrasound and CT), new ulcers and intake of painkillers.

Enrollment: 4 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age of 18
• Calcinosis cutis due to connective tissue disease
• information about ESWT given
• Patient understands the study and signs the informed consent

Exclusion criteria

• No ESWT done
• cuagulopathy
• sepsis
• pregnancy
• pace maker
• severe disease in the opinion of the investigator
• cardiac risk with NYHA III-IV
• Ehlers-Danlos-Syndrome

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

4 participants in 1 patient group

shock wave therapy

Experimental group

Description:

intervention: shock wave therapy with Modulith SLK (Storz)

Treatment:

Device: shock wave therapy with Modulith SLK (Storz)